Larvol Delta - Longterm-Followup-of-Study-Participant-Treated-With-LentiviralBased-Genetically-Modified-Autologous-Cell-Product-AGT103T

AGT103-T - American Gene Technologies

http://clinicaltrials.gov/ct2/show/NCT05529342

Sep 7, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next